pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Pharma patent portfolio — 185 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 7
- Drugs
- 407
- Patents
- 185
Teva Pharma patents
185 pharmaceutical patents indexed for Teva Pharma. 22 expire within 24 months.
Teva Pharma has 185 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 22 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 7148376
Polymorphic forms of nateglinide
granted -
US 7138137
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
granted -
US 7126008
Carvedilol
granted -
US 7060837
Method for the purification of lansoprazole
granted -
US 7056942
Carvedilol
granted -
US 7033582
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
expired -
US 7022859
Method for the purification of lansoprazole
expired -
US 7022881
Sertraline hydrochloride polymorphs
expired -
US 7001919
Forms of pravastatin sodium
expired -
US 6987175
Processes for preparing clarithromycin polymorphs
expired -
US 6936731
Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
expired -
US 6930186
Process for the preparation of paroxetine substantially free of alkoxy impurities
expired -
US 6909004
Method for the purification of lansoprazole
expired -
US 6884888
Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)
expired -
US 6861553
Process for preparing nateglinide and intermediates thereof
expired -
US 6861426
Crystal forms of lamotrigine and processes for their preparations
expired -
US 6858652
Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
expired -
US 6849120
Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms
expired -
US 6849736
Crystalline forms of valacyclovir hydrochloride
expired -
US 6806373
Process for preparing leflunomide form I
expired -
US 6774230
Methods for the preparation of mirtazapine intermediates
expired -
US 6764997
Stabilized azithromycin compositions
expired -
US 6750341
Preparation of risperidone
expired -
US 6723855
Method for synthesizing leflunomide
expired -
US 6710184
Crystalline solids of carvedilol and processes for their preparation
expired -
US 6699997
Carvedilol
expired -
US 6696601
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
expired -
US 6689384
Stable pergolide mesylate and process for making same
expired -
US 6624292
Processes for preparing clarithromycin polymorphs
expired -
US 6610718
Processes for making- and a new crystalline form of- leflunomide
expired -
US 6600073
Methods for preparation of sertraline hydrochloride polymorphs
expired -
US 6599884
Processes for preparing clarithromycin polymorphs and novel polymorph IV
expired -
US 6569459
Method of administration of paclitaxel-plasma protein formulation
expired -
US 6500987
Sertraline hydrochloride polymorphs
expired -
US 6495721
Sertraline hydrochloride Form II and methods for the preparation thereof
expired -
US 6476006
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
expired -
US 6452054
Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
expired -
US 6365574
Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
expired -
US 6306436
Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
expired -
US 6281381
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
expired -
US 6248888
Process for the preparation of terazosin hydrochloride dihydrate
expired
Frequently asked questions
How many patents does Teva Pharma have?
185 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Teva Pharma patents expire?
22 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.